Financial News · Live Terminal

Page 33 of 519

TA Securities Upgrades SD Guthrie to Buy from Hold; Price Target is MYR7.36

SD Guthrie (KLSE:SDG) has an average rating of overweight and mean price target of 7.69 ringgit, according to analysts polled by FactSet.

KLSE:SDG

Research13d ago

RHB Research Institute Upgrades Bermaz Auto to Buy from Neutral; Price Target is MYR1.15

Bermaz Auto (KLSE:BAUTO) has an average rating of buy and mean price target of 1.18 ringgit, according to analysts polled by FactSet.

KLSE:BAUTO

Research13d ago

Ord Minnett Downgrades Westgold Resources to Accumulate from Buy; Price Target is AU$6.50

Westgold Resources (ASX:WGX) has an average rating of buy and mean price target of AU$7.21, according to analysts polled by FactSet.

ASX:WGX

Research13d ago

CLSA Starts Yunnan Energy New Material at Accumulate with 67 Yuan Price Target

Yunnan Energy New Material (SHE:002812) has an average rating of buy and mean price target of 72.26 yuan, according to analysts polled by FactSet.

SHE:002812

Research13d ago

Krungsri Securities Upgrades Thai Oil to Buy from Neutral; Price Target is THB83

Thai Oil (BKK:TOP) has an average rating of overweight and mean price target of 72.28 baht, according to analysts polled by FactSet.

BKK:TOP

Research13d ago

PT Verdhana Sekuritas Indonesia Starts Hartadinata Abadi at Buy with IDR2,900 Price Target

IDX:HRTA

Research13d ago

Mirae Asset Securities Downgrades Charoen Pokphand Indonesia to Hold from Accumulate; Price Target is IDR3,550

Charoen Pokphand Indonesia (IDX:CPIN) has an average rating of overweight and mean price target of 4,243.33 rupiah, according to analysts polled by FactSet.

IDX:CPIN

Research13d ago

Mirae Asset Securities Starts Ha Do Group JSC at Buy with VND21,100 Price Target

HOSE:HDG

Research13d ago

Bahana Securities Downgrades Erajaya Swasembada to Hold from Buy; Price Target is IDR650

IDX:ERAA

Research13d ago

KeyBanc Initiates CF Industries Holdings at Underweight With $115 Price Target

CF Industries Holdings (CF) has an average rating of hold and mean price target of $124.43, according to analysts polled by FactSet.

$CF

Research13d ago

KeyBanc Initiates Nutrien at Sector Weight

Nutrien (NTR) has an average rating of overweight and mean price target of $76.97, according to analysts polled by FactSet.

$NTR

Research13d ago

KeyBanc Initiates Mosaic at Sector Weight

Mosaic (MOS) has an average rating of overweight and mean price target of $26.29, according to analysts polled by FactSet.

$MOS

Research13d ago

UBS Initiates Korsana Biosciences at Buy With $55 Price Target

$KRSA

Research13d ago

Wells Fargo Initiates Bread Financial at Equalweight

Bread Financial Holdings (BFH) has an average rating of overweight and mean price target of $117.69, according to analysts polled by FactSet.

$BFH

Research13d ago

Morgan Stanley Initiates Kodiak AI at Equalweight With $9 Price Target

Kodiak AI (KDK) has an average rating of buy and mean price target of $10.69, according to analysts polled by FactSet.

$KDK

Research13d ago

JPMorgan Initiates Old National Bancorp at Overweight With $32 Price Target

Old National Bancorp (ONB) has an average rating of overweight and mean price target of $30, according to analysts polled by FactSet.

$ONB

Research13d ago

Mizuho Initiates Chesapeake Utilities at Outperform

Chesapeake Utilities (CPK) has an average rating of overweight and mean price target of $147.30, according to analysts polled by FactSet.

$CPK

Research13d ago

UBS Downgrades NuScale Power to Sell From Neutral, Adjusts Price Target to $6 From $10

NuScale Power (SMR) has an average rating of hold and mean price target of $12.37, according to analysts polled by FactSet.

$SMR

Research13d ago

JPMorgan Downgrades Chewy to Neutral From Overweight, Adjusts Price Target to $24 From $29

Chewy (CHWY) has an average rating of overweight and mean price target of $28.32, according to analysts polled by FactSet.

$CHWY

Research13d ago

Morgan Stanley Downgrades Novo Nordisk to Underweight From Equalweight, Price Target is $40

Novo Nordisk A/S (NVO) has an average rating of hold and mean price target of $44.50, according to analysts polled by FactSet.

$NVO

Showing 641-660 of 10370